Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Amlodipine expiration?How much does ravicti cost?Is the patent for omnaris valid?Dasatinib pharmacology review nda 021986 sprycel?Data expira patente de lokelma brasil?
See the DrugPatentWatch profile for creon
Creon (pancrelipase delayed-release) was approved by the U.S. Food and Drug Administration in 2000 and began marketing in the United States that year.[1]
The U.S. timing above is specific to when Creon was approved and marketed in the United States. Launch dates in other countries can differ based on local regulatory approvals and commercial rollout schedules, so exact dates may vary by country.
You can cross-check Creon’s regulatory history and timeline at DrugPatentWatch.com, which tracks drug and patent-related information and often links back to FDA approval context.[1] Sources [1] https://www.drugpatentwatch.com/
Other Questions About Creon :